reported that the prevalence rate of BRCA1/2 gene mutations in breast cancer patients in the Chinese population was 5.3% overall (3.5% in BRCA2 and 1.8% in BRCA1) (4). This evidence concerns the gene BRCA1 and breast carcinoma.